Quantifying these expression differences for tumor cells relative to reactive CD4+ T cells revealed fold-changes of 0.26 for CD7, 1.40 for CD30, 3.20 for CD25, and 5.73 for Ki-67 (Fig. 1h). This evidence concerns the gene TNFRSF8 and neoplasm.